Klinische Studien UKRO

Establishing Novel MR - Criteria for the Assessment of Malignant Glioma Progression
SNF: 320030_140958
Inselspital PhD. J. Slotboom, Prof. Dr. med. R. Wiest, Prof. Dr. med. A. Raabe, PD Dr. med. A. Pica
Activated

SAKK 09/10
Dose intensified salvage radiotherapy in biochemically relapsed prostate cancer without macroscopic disease. A randomized phase III trial.
Inselspital: Dr. med. A. Dal Pra
Activated
http://www.sakk.ch/ 
http://www.clinicaltrials.gov/ct2/show/NCT01272050 
www.sakk0910rt.ch

Radiation metabolic signature of patients undergoing radiotherapy. A Pilot Study.
Inselspital: Dr. med. K. Lössl
Activated

PET-Plan
Optimierung der Strahlentherapieplanung von Patienten mit inoperablen lokal fortgeschrittenen nicht-kleinzelligen Bronchialkarzinome mittels F-18-FDG. Prospektive randomisierte multizentrische Therapieoptimierungsstudie.
Inselspital: Dr. med. M. Schmücking
Activated

SAKK 01/10 - EudraCT No. 2011-005840-87
Carboplatin chemotherapy and involved node radiotherapy in Stage IIA/IIB Semonima.
Inselspital:Prof.Dr. med. D. Aebersold
Activated
http://www.sakk.ch/

IELSG 37
A randomized, open-label, multicenter, two-arm phase III comparative study assessing the role of mediastinal radiotherapy after Rituximab containing chemotherapy regiments to patients with newly diagnosed Primary Mediastinal Large B-Cell Lymphoma (PMLBCL).
Inselspital: Dr. med. C. Ionescu
Activated
http://www.ielsg.org/

CHUV-CePO-20080214
Phase II study of concomitant intensity-modulated radiotherapy combined to capecitabine, mitomycin and panitumumab in patients with stage II -IIIB squamous-cell carcinoma of the anal canal
Inselspital: Dr. med. E. Herrmann
Activation in process

IBCSG 38-10/BIG 3-07/TROG 07.01
Randomisierte Phase III Studie zu Bestrahlungsdosen und Fraktionierungsschemata 
bei duktalem Carcinoma in situ (DCIS) der Brust mit mittlerem und hohem Rückfall-Risiko.
Inselspital: Dr. med. K. Lössl
Activated

SAKK 77/07
External Beam Radiotherapy for unresectable hepatocellular carcinoma. A Multicenter phase I/II Trail. Trial-Chair: Dr. med. E. Herrmann, Inselspital: Dr. med. E. Herrmann 
Closed
Link SAKK : http://www.sakk.ch/ 

EORTC 22042-26042
Adjuvant postoperative high-dose radiotherapy for atypical and malignant meningioma: a Phase-II and observation study
Activated
Inselspital: PD Dr. A. Pica
Closed
http://www.eortc.be

SAKK 15/12
Early prophylactic cranial irradiation with hippocampal avoidance in patients with limited disease small-cell lung cancer. A multicenter phase II trial
Inselspital: Dr. med. M. Schmücking
Activation in process

Med. Onkologie und UKRO 

SAKK 16/08 
Preoperative chemotherapy and radiotherapy concomitant to Cetuximab in non-small cell lung cancer (NSCLC) patients with IIIB disease. A multicenter phase II trial.
Inselspital: Prof. A. Ochsenbein
Activated
http://www.sakk.ch/

SAKK 75/08 / EudraCT Nr.: 2009-016584-10
Multimodal therapy with and without cetuximab in patients with locally advanced esophageal carcinoma.
An open-label phase III trial
Closed
Inselspital: Dr. M. Zweifel
http://www.sakk.ch/

HD18 / EudraCT Nr.: 2007-003187-22
for advanced stages: Treatment optimization trial in the first-line treatment of advanced stage Hodgkin lymphoma: treatment stratification by means of FDG-PET
Inselspital: Prof. Th. Pabst
Activated
Link Homepage: http://www.ghsg.org

HD 16 / EudraCT Nr.: 2007-04474-24
für frühe Stadien Therapieoptimierungsstudie in der Primärtherapie des frühen Hodgkin Lymphom. Therapiestratifizierung mittels FDG-FET
Inselspital: Prof. Th. Pabst
Activated
Link Homepage: http://www.ghsg.org

HD17 for intermediate stages
Treatment optimization trial in the first-line treatment of intermediate stage of Hodgkin lymphoma; treatment stratification by means of FDG-PET
Activated
Inselspital: Prof. Th. Pabst

STAMPEDE /EudraCT Nr.:2004-000193-31
Systemic Therapy in Advancing or Metastatic Prostate Cancer: Evaluation of Drug Efficacy.
Activated

Multizenter-APBI-Phase-III-Studie
Studienkontakt Bern: Dr. med. Kristina Lössl, Email: kristina.loessl@no-spaminsel.ch